The CMS gave the green light to Michigan Medicaid’s outcome-based drug proposal, the second of its kind. Oklahoma has yet to forecast savings from its similar state plan amendment approved in June.
Medicaid OKs Michigan waiver to negotiate drug prices based on outcomes
